MoonLake Immunotherapeutics (MLTX) Q2 2023 Earnings

30AugExpected
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.34
-0.23
-0.11
0

Details

Expected EPS
-0.244
Actual EPS
0
Surprise EPS
0.24
Surprise Percent
+100%

Description

MoonLake Immunotherapeutics (MLTX) will report earnings of for Q2 2023 on August 30, 2023.

0 Comments

Share your thoughts